TOCA News and Press, Tocagen From 06/12/19

Gainers:  Synlogic (NASDAQ: SYBX ) +28% . Immuron (NASDAQ: IMRN ) +26% . B Communications (NASDAQ: BCOM ) +23% . Arcadia Biosciences (NASDAQ: RKDA ) +17% . Vuzix Corporation (NASDAQ: VUZI ) +14% . MagnaChip Semiconductor Corporation (NYSE: MX ) +13% . Osmotica Pharmaceuticals (N...

That's all the freedom we can hope for - the freedom to choose our prison. " - L.M. Montgomery, The Blue Castle The market finally broke a six-week losing streak last week. A punk Jobs Report on Friday confirmed the most likely next move from the Federal Reserve is an interest rate cut. T...

Gainers:  Obalon Therapeutics (NASDAQ: OBLN ) +42% . Eltek (NASDAQ: ELTK ) +35% . SilverSun Technologies (NASDAQ: SSNT ) +33% . MiMedx Group ( OTC:MDXG ) +31% . BioCryst Pharmaceuticals (NASDAQ: BCRX ) +19% . Tocagen (NASDAQ: TOCA ) +17% . Hydrogenics Corporation (NASDAQ: HYGS )...

SAN DIEGO , May 30, 2019 /PRNewswire/ --  Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced Marty Duvall , chief executive officer, will present at the Jefferies 2019 Healthcare Conference on Thursday, June 6 , at 4:00 p.m. ET ...

Gainers:  Novan (NASDAQ: NOVN ) +27% . Sea Limited (NYSE: SE ) +23% . Allied Healthcare Products (NASDAQ: AHPI ) +17% . Westwater Resources (NASDAQ: WWR ) +12% . Novus Therapeutics (NASDAQ: NVUS ) +12% . Spherix Incorporated (NASDAQ: SPEX ) +11% . CSW Industrials (NASDAQ: CSWI )...

OncoSec Medical (NASDAQ: ONCS )  -31%  on pricing equity offering. More news on: OncoSec Medical Incorporated, Ekso Bionics Holdings, Inc., Tocagen Inc., Stocks on the move, Read more ...

Gainers: CVI   +3.7% . PVH   +3.2% . More news on: CVR Energy, Inc., PVH Corp., Tocagen Inc., Stocks on the move, Read more ...

Apparently expecting better news, investors head for the exits after Tocagen (NASDAQ: TOCA ) reported that its Phase 3 clinical trial, Toca 5 , evaluating Toca 511 & Toca FC in patients with recurrent high grade glioma will continue without modification. The decision was based on a pr...

SAN DIEGO , May 21, 2019 /PRNewswire/ --  Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced the Toca 5 Phase 3 clinical trial evaluating Toca 511 & Toca FC in patients with recurrent high grade glioma (HGG) continues without mo...

Tocagen (NASDAQ: TOCA ): Q1 GAAP EPS of -$0.74 beats by $0.03 . Cash and equivalents of $80.1M. Press Release More news on: Tocagen Inc., Earnings news and commentary, Healthcare stocks news, ,